3.26.1 html 539 462 1 true 145 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.novabaypharma.com/20251231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.novabaypharma.com/20251231/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.novabaypharma.com/20251231/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations Sheet http://www.novabaypharma.com/20251231/role/statement-consolidated-statements-of-operations Consolidated Statements of Operations Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Stockholders' (Deficit) Equity Sheet http://www.novabaypharma.com/20251231/role/statement-consolidated-statements-of-stockholders-deficit-equity Consolidated Statements of Stockholders' (Deficit) Equity Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Stockholders' (Deficit) Equity (Parentheticals) Sheet http://www.novabaypharma.com/20251231/role/statement-consolidated-statements-of-stockholders-deficit-equity-parentheticals Consolidated Statements of Stockholders' (Deficit) Equity (Parentheticals) Statements 6 false false R7.htm 006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.novabaypharma.com/20251231/role/statement-consolidated-statements-of-cash-flows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 007 - Statement - Consolidated Statements of Cash Flows Sheet http://www.novabaypharma.com/20251231/role/statement-consolidated-statements-of-cash-flowsA866F64D-8A89-45C0-926D-49809D27BFD0 Consolidated Statements of Cash Flows Statements 8 false false R9.htm 008 - Statement - Consolidated Statements of Cash Flows Sheet http://www.novabaypharma.com/20251231/role/statement-consolidated-statements-of-cash-flows4D8E0948-3376-4886-A031-7AF56055462E Consolidated Statements of Cash Flows Statements 9 false false R10.htm 995443 - Disclosure - Award Timing Disclosure Sheet http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure Award Timing Disclosure Notes 10 false false R11.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 11 false false R12.htm 995447 - Disclosure - Insider Trading Policies and Procedures Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc Insider Trading Policies and Procedures Notes 12 false false R13.htm 995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure Sheet http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure Cybersecurity Risk Management and Strategy Disclosure Notes 13 false false R14.htm 995550 - Disclosure - Note 1 - Organization Sheet http://www.novabaypharma.com/20251231/role/statement-note-1-organization Note 1 - Organization Notes 14 false false R15.htm 995551 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.novabaypharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 15 false false R16.htm 995552 - Disclosure - Note 3 - Fair Value Measurements Sheet http://www.novabaypharma.com/20251231/role/statement-note-3-fair-value-measurements Note 3 - Fair Value Measurements Notes 16 false false R17.htm 995553 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets Sheet http://www.novabaypharma.com/20251231/role/statement-note-4-prepaid-expenses-and-other-current-assets Note 4 - Prepaid Expenses and Other Current Assets Notes 17 false false R18.htm 995554 - Disclosure - Note 5 - Accrued Liabilities Sheet http://www.novabaypharma.com/20251231/role/statement-note-5-accrued-liabilities Note 5 - Accrued Liabilities Notes 18 false false R19.htm 995555 - Disclosure - Note 6 - Commitments and Contingencies Sheet http://www.novabaypharma.com/20251231/role/statement-note-6-commitments-and-contingencies Note 6 - Commitments and Contingencies Notes 19 false false R20.htm 995556 - Disclosure - Note 7 - Financing Activities Sheet http://www.novabaypharma.com/20251231/role/statement-note-7-financing-activities Note 7 - Financing Activities Notes 20 false false R21.htm 995557 - Disclosure - Note 8 - Convertible Notes Notes http://www.novabaypharma.com/20251231/role/statement-note-8-convertible-notes Note 8 - Convertible Notes Notes 21 false false R22.htm 995558 - Disclosure - Note 9 - Common Stock Warrants and Warrant Liabilities Sheet http://www.novabaypharma.com/20251231/role/statement-note-9-common-stock-warrants-and-warrant-liabilities Note 9 - Common Stock Warrants and Warrant Liabilities Notes 22 false false R23.htm 995559 - Disclosure - Note 10 - Stockholders' Deficit Sheet http://www.novabaypharma.com/20251231/role/statement-note-10-stockholders-deficit Note 10 - Stockholders' Deficit Notes 23 false false R24.htm 995560 - Disclosure - Note 11 - Stock-based Compensation Sheet http://www.novabaypharma.com/20251231/role/statement-note-11-stockbased-compensation Note 11 - Stock-based Compensation Notes 24 false false R25.htm 995561 - Disclosure - Note 12 - Employee Benefit Plan Sheet http://www.novabaypharma.com/20251231/role/statement-note-12-employee-benefit-plan Note 12 - Employee Benefit Plan Notes 25 false false R26.htm 995562 - Disclosure - Note 13 - Avenova Asset Divestiture and Bridge Loan Sheet http://www.novabaypharma.com/20251231/role/statement-note-13-avenova-asset-divestiture-and-bridge-loan Note 13 - Avenova Asset Divestiture and Bridge Loan Notes 26 false false R27.htm 995563 - Disclosure - Note 14 - Phaseone Divestiture Sheet http://www.novabaypharma.com/20251231/role/statement-note-14-phaseone-divestiture Note 14 - Phaseone Divestiture Notes 27 false false R28.htm 995564 - Disclosure - Note 15 - Dermadoctor Divestiture Sheet http://www.novabaypharma.com/20251231/role/statement-note-15-dermadoctor-divestiture Note 15 - Dermadoctor Divestiture Notes 28 false false R29.htm 995565 - Disclosure - Note 16 - Summary of Discontinued Operations Sheet http://www.novabaypharma.com/20251231/role/statement-note-16-summary-of-discontinued-operations Note 16 - Summary of Discontinued Operations Notes 29 false false R30.htm 995566 - Disclosure - Note 17 - Income Taxes Sheet http://www.novabaypharma.com/20251231/role/statement-note-17-income-taxes Note 17 - Income Taxes Notes 30 false false R31.htm 995567 - Disclosure - Note 18 - Related Party Transactions Sheet http://www.novabaypharma.com/20251231/role/statement-note-18-related-party-transactions Note 18 - Related Party Transactions Notes 31 false false R32.htm 995568 - Disclosure - Note 19 - Subsequent Events Sheet http://www.novabaypharma.com/20251231/role/statement-note-19-subsequent-events Note 19 - Subsequent Events Notes 32 false false R33.htm 995569 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.novabaypharma.com/20251231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.novabaypharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies 33 false false R34.htm 995570 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://www.novabaypharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-tables Note 2 - Summary of Significant Accounting Policies (Tables) Tables http://www.novabaypharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies 34 false false R35.htm 995571 - Disclosure - Note 3 - Fair Value Measurements (Tables) Sheet http://www.novabaypharma.com/20251231/role/statement-note-3-fair-value-measurements-tables Note 3 - Fair Value Measurements (Tables) Tables http://www.novabaypharma.com/20251231/role/statement-note-3-fair-value-measurements 35 false false R36.htm 995572 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.novabaypharma.com/20251231/role/statement-note-4-prepaid-expenses-and-other-current-assets-tables Note 4 - Prepaid Expenses and Other Current Assets (Tables) Tables http://www.novabaypharma.com/20251231/role/statement-note-4-prepaid-expenses-and-other-current-assets 36 false false R37.htm 995573 - Disclosure - Note 5 - Accrued Liabilities (Tables) Sheet http://www.novabaypharma.com/20251231/role/statement-note-5-accrued-liabilities-tables Note 5 - Accrued Liabilities (Tables) Tables http://www.novabaypharma.com/20251231/role/statement-note-5-accrued-liabilities 37 false false R38.htm 995574 - Disclosure - Note 6 - Commitments and Contingencies (Tables) Sheet http://www.novabaypharma.com/20251231/role/statement-note-6-commitments-and-contingencies-tables Note 6 - Commitments and Contingencies (Tables) Tables http://www.novabaypharma.com/20251231/role/statement-note-6-commitments-and-contingencies 38 false false R39.htm 995575 - Disclosure - Note 9 - Common Stock Warrants and Warrant Liabilities (Tables) Sheet http://www.novabaypharma.com/20251231/role/statement-note-9-common-stock-warrants-and-warrant-liabilities-tables Note 9 - Common Stock Warrants and Warrant Liabilities (Tables) Tables http://www.novabaypharma.com/20251231/role/statement-note-9-common-stock-warrants-and-warrant-liabilities 39 false false R40.htm 995576 - Disclosure - Note 11 - Stock-based Compensation (Tables) Sheet http://www.novabaypharma.com/20251231/role/statement-note-11-stockbased-compensation-tables Note 11 - Stock-based Compensation (Tables) Tables http://www.novabaypharma.com/20251231/role/statement-note-11-stockbased-compensation 40 false false R41.htm 995577 - Disclosure - Note 13 - Avenova Asset Divestiture and Bridge Loan (Tables) Sheet http://www.novabaypharma.com/20251231/role/statement-note-13-avenova-asset-divestiture-and-bridge-loan-tables Note 13 - Avenova Asset Divestiture and Bridge Loan (Tables) Tables http://www.novabaypharma.com/20251231/role/statement-note-13-avenova-asset-divestiture-and-bridge-loan 41 false false R42.htm 995578 - Disclosure - Note 14 - Phaseone Divestiture (Tables) Sheet http://www.novabaypharma.com/20251231/role/statement-note-14-phaseone-divestiture-tables Note 14 - Phaseone Divestiture (Tables) Tables http://www.novabaypharma.com/20251231/role/statement-note-14-phaseone-divestiture 42 false false R43.htm 995579 - Disclosure - Note 15 - Dermadoctor Divestiture (Tables) Sheet http://www.novabaypharma.com/20251231/role/statement-note-15-dermadoctor-divestiture-tables Note 15 - Dermadoctor Divestiture (Tables) Tables http://www.novabaypharma.com/20251231/role/statement-note-15-dermadoctor-divestiture 43 false false R44.htm 995580 - Disclosure - Note 16 - Summary of Discontinued Operations (Tables) Sheet http://www.novabaypharma.com/20251231/role/statement-note-16-summary-of-discontinued-operations-tables Note 16 - Summary of Discontinued Operations (Tables) Tables http://www.novabaypharma.com/20251231/role/statement-note-16-summary-of-discontinued-operations 44 false false R45.htm 995581 - Disclosure - Note 17 - Income Taxes (Tables) Sheet http://www.novabaypharma.com/20251231/role/statement-note-17-income-taxes-tables Note 17 - Income Taxes (Tables) Tables http://www.novabaypharma.com/20251231/role/statement-note-17-income-taxes 45 false false R46.htm 995582 - Disclosure - Note 1 - Organization (Details Textual) Sheet http://www.novabaypharma.com/20251231/role/statement-note-1-organization-details-textual Note 1 - Organization (Details Textual) Details http://www.novabaypharma.com/20251231/role/statement-note-1-organization 46 false false R47.htm 995583 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.novabaypharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://www.novabaypharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-tables 47 false false R48.htm 995584 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-schedule-of-cash-cash-equivalents-restricted-cash-and-restricted-cash-equivalents-details Note 2 - Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details) Details 48 false false R49.htm 995585 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-schedule-of-earnings-per-share-basic-and-diluted-details Note 2 - Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Details) Details 49 false false R50.htm 995586 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-schedule-of-antidilutive-securities-excluded-from-computation-of-earnings-per-share-details Note 2 - Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Details 50 false false R51.htm 995587 - Disclosure - Note 3 - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-3-fair-value-measurements-assets-and-liabilities-measured-at-fair-value-on-a-recurring-basis-details Note 3 - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 51 false false R52.htm 995588 - Disclosure - Note 3 - Fair Value Measurements - Fair Value Valuation Assumptions (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-3-fair-value-measurements-fair-value-valuation-assumptions-details Note 3 - Fair Value Measurements - Fair Value Valuation Assumptions (Details) Details 52 false false R53.htm 995589 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) Details 53 false false R54.htm 995590 - Disclosure - Note 5 - Accrued Liabilities - Summary of Accrued Liabilities (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-5-accrued-liabilities-summary-of-accrued-liabilities-details Note 5 - Accrued Liabilities - Summary of Accrued Liabilities (Details) Details 54 false false R55.htm 995591 - Disclosure - Note 6 - Commitments and Contingencies (Details Textual) Sheet http://www.novabaypharma.com/20251231/role/statement-note-6-commitments-and-contingencies-details-textual Note 6 - Commitments and Contingencies (Details Textual) Details http://www.novabaypharma.com/20251231/role/statement-note-6-commitments-and-contingencies-tables 55 false false R56.htm 995592 - Disclosure - Note 6 - Commitments and Contingencies - Lease Expense (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-6-commitments-and-contingencies-lease-expense-details Note 6 - Commitments and Contingencies - Lease Expense (Details) Details 56 false false R57.htm 995593 - Disclosure - Note 6 - Commitments and Contingencies - Schedule of Future Lease Payments (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-6-commitments-and-contingencies-schedule-of-future-lease-payments-details Note 6 - Commitments and Contingencies - Schedule of Future Lease Payments (Details) Details 57 false false R58.htm 995594 - Disclosure - Note 7 - Financing Activities (Details Textual) Sheet http://www.novabaypharma.com/20251231/role/statement-note-7-financing-activities-details-textual Note 7 - Financing Activities (Details Textual) Details http://www.novabaypharma.com/20251231/role/statement-note-7-financing-activities 58 false false R59.htm 995595 - Disclosure - Note 8 - Convertible Notes (Details Textual) Notes http://www.novabaypharma.com/20251231/role/statement-note-8-convertible-notes-details-textual Note 8 - Convertible Notes (Details Textual) Details http://www.novabaypharma.com/20251231/role/statement-note-8-convertible-notes 59 false false R60.htm 995596 - Disclosure - Note 9 - Common Stock Warrants and Warrant Liabilities (Details Textual) Sheet http://www.novabaypharma.com/20251231/role/statement-note-9-common-stock-warrants-and-warrant-liabilities-details-textual Note 9 - Common Stock Warrants and Warrant Liabilities (Details Textual) Details http://www.novabaypharma.com/20251231/role/statement-note-9-common-stock-warrants-and-warrant-liabilities-tables 60 false false R61.htm 995597 - Disclosure - Note 9 - Common Stock Warrants and Warrant Liabilities - Schedule of Stockholders' Equity Note, Warrants or Rights (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-9-common-stock-warrants-and-warrant-liabilities-schedule-of-stockholders-equity-note-warrants-or-rights-details Note 9 - Common Stock Warrants and Warrant Liabilities - Schedule of Stockholders' Equity Note, Warrants or Rights (Details) Details 61 false false R62.htm 995598 - Disclosure - Note 9 - Common Stock Warrants and Warrant Liabilities (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-9-common-stock-warrants-and-warrant-liabilities-details Note 9 - Common Stock Warrants and Warrant Liabilities (Details) Details http://www.novabaypharma.com/20251231/role/statement-note-9-common-stock-warrants-and-warrant-liabilities-tables 62 false false R63.htm 995599 - Disclosure - Note 10 - Stockholders' Deficit (Details Textual) Sheet http://www.novabaypharma.com/20251231/role/statement-note-10-stockholders-deficit-details-textual Note 10 - Stockholders' Deficit (Details Textual) Details http://www.novabaypharma.com/20251231/role/statement-note-10-stockholders-deficit 63 false false R64.htm 995600 - Disclosure - Note 11 - Stock-based Compensation (Details Textual) Sheet http://www.novabaypharma.com/20251231/role/statement-note-11-stockbased-compensation-details-textual Note 11 - Stock-based Compensation (Details Textual) Details http://www.novabaypharma.com/20251231/role/statement-note-11-stockbased-compensation-tables 64 false false R65.htm 995601 - Disclosure - Note 11 - Stock-based Compensation - Stock Options Outstanding (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-11-stockbased-compensation-stock-options-outstanding-details Note 11 - Stock-based Compensation - Stock Options Outstanding (Details) Details 65 false false R66.htm 995602 - Disclosure - Note 12 - Employee Benefit Plan (Details Textual) Sheet http://www.novabaypharma.com/20251231/role/statement-note-12-employee-benefit-plan-details-textual Note 12 - Employee Benefit Plan (Details Textual) Details http://www.novabaypharma.com/20251231/role/statement-note-12-employee-benefit-plan 66 false false R67.htm 995603 - Disclosure - Note 13 - Avenova Asset Divestiture and Bridge Loan (Details Textual) Sheet http://www.novabaypharma.com/20251231/role/statement-note-13-avenova-asset-divestiture-and-bridge-loan-details-textual Note 13 - Avenova Asset Divestiture and Bridge Loan (Details Textual) Details http://www.novabaypharma.com/20251231/role/statement-note-13-avenova-asset-divestiture-and-bridge-loan-tables 67 false false R68.htm 995604 - Disclosure - Note 13 - Avenova Asset Divestiture and Bridge Loan - Discontinued Operations (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-13-avenova-asset-divestiture-and-bridge-loan-discontinued-operations-details Note 13 - Avenova Asset Divestiture and Bridge Loan - Discontinued Operations (Details) Details 68 false false R69.htm 995605 - Disclosure - Note 14 - Phaseone Divestiture (Details Textual) Sheet http://www.novabaypharma.com/20251231/role/statement-note-14-phaseone-divestiture-details-textual Note 14 - Phaseone Divestiture (Details Textual) Details http://www.novabaypharma.com/20251231/role/statement-note-14-phaseone-divestiture-tables 69 false false R70.htm 995606 - Disclosure - Note 14 - Phaseone Divestiture - Held-for-sale (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-14-phaseone-divestiture-heldforsale-details Note 14 - Phaseone Divestiture - Held-for-sale (Details) Details 70 false false R71.htm 995607 - Disclosure - Note 15 - Dermadoctor Divestiture (Details Textual) Sheet http://www.novabaypharma.com/20251231/role/statement-note-15-dermadoctor-divestiture-details-textual Note 15 - Dermadoctor Divestiture (Details Textual) Details http://www.novabaypharma.com/20251231/role/statement-note-15-dermadoctor-divestiture-tables 71 false false R72.htm 995608 - Disclosure - Note 15 - Dermadoctor Divestiture - Discontinued Operations (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-15-dermadoctor-divestiture-discontinued-operations-details Note 15 - Dermadoctor Divestiture - Discontinued Operations (Details) Details 72 false false R73.htm 995609 - Disclosure - Note 16 - Summary of Discontinued Operations - Disposal Groups, Including Discontinued Operations (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-16-summary-of-discontinued-operations-disposal-groups-including-discontinued-operations-details Note 16 - Summary of Discontinued Operations - Disposal Groups, Including Discontinued Operations (Details) Details 73 false false R74.htm 995610 - Disclosure - Note 17 - Income Taxes (Details Textual) Sheet http://www.novabaypharma.com/20251231/role/statement-note-17-income-taxes-details-textual Note 17 - Income Taxes (Details Textual) Details http://www.novabaypharma.com/20251231/role/statement-note-17-income-taxes-tables 74 false false R75.htm 995611 - Disclosure - Note 17 - Income Taxes - Loss Before Provision for Income Taxes (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-17-income-taxes-loss-before-provision-for-income-taxes-details Note 17 - Income Taxes - Loss Before Provision for Income Taxes (Details) Details 75 false false R76.htm 995612 - Disclosure - Note 17 - Income Taxes - Federal and State Income Tax Provisions (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-17-income-taxes-federal-and-state-income-tax-provisions-details Note 17 - Income Taxes - Federal and State Income Tax Provisions (Details) Details 76 false false R77.htm 995613 - Disclosure - Note 17 - Income Taxes - Summary of Deferred Tax Assets and Liabilities (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-17-income-taxes-summary-of-deferred-tax-assets-and-liabilities-details Note 17 - Income Taxes - Summary of Deferred Tax Assets and Liabilities (Details) Details 77 false false R78.htm 995614 - Disclosure - Note 17 - Income Taxes - Summary of Net operating Loss and Tax Credit Carryforwards (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-17-income-taxes-summary-of-net-operating-loss-and-tax-credit-carryforwards-details Note 17 - Income Taxes - Summary of Net operating Loss and Tax Credit Carryforwards (Details) Details 78 false false R79.htm 995615 - Disclosure - Note 17 - Income Taxes - Unrecognized Tax Benefit (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-17-income-taxes-unrecognized-tax-benefit-details Note 17 - Income Taxes - Unrecognized Tax Benefit (Details) Details 79 false false R80.htm 995616 - Disclosure - Note 17 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-17-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details Note 17 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) Details 80 false false R81.htm 995617 - Disclosure - Note 17 - Income Taxes - Schedule of Income Tax Paid, Net of Refunds (Details) Sheet http://www.novabaypharma.com/20251231/role/statement-note-17-income-taxes-schedule-of-income-tax-paid-net-of-refunds-details Note 17 - Income Taxes - Schedule of Income Tax Paid, Net of Refunds (Details) Details 81 false false R82.htm 995618 - Disclosure - Note 18 - Related Party Transactions (Details Textual) Sheet http://www.novabaypharma.com/20251231/role/statement-note-18-related-party-transactions-details-textual Note 18 - Related Party Transactions (Details Textual) Details http://www.novabaypharma.com/20251231/role/statement-note-18-related-party-transactions 82 false false R83.htm 995619 - Disclosure - Note 19 - Subsequent Events (Details Textual) Sheet http://www.novabaypharma.com/20251231/role/statement-note-19-subsequent-events-details-textual Note 19 - Subsequent Events (Details Textual) Details http://www.novabaypharma.com/20251231/role/statement-note-19-subsequent-events 83 false false All Reports Book All Reports nby-20251231.xsd nby-20251231_cal.xml nby-20251231_def.xml nby-20251231_lab.xml nby-20251231_pre.xml nby20251231_10k.htm bar01.jpg bar02.jpg http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/cyd/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 true true